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Total syntheses of disulphated glycosphingolipid
SB1a and the related monosulphated SM1a†
Haruka Hirose,a Hideki Tamai,a Chao Gao,b Akihiro Imamura,*a Hiromune Ando,a,c
Hideharu Ishida,a Ten Feizib and Makoto Kiso*a,c
Total syntheses of two natural sulphoglycolipids, disulphated glycosphingolipid SB1a and the structurally
related monosulphated SM1a, are described. They have common glycan sequences and ceramide
moieties and are associated with human epithelial carcinomas. The syntheses featured eﬃcient glycan
assembly and the glucosyl ceramide cassette as a versatile building block. The binding of the synthetic
sulphoglycolipids by the carcinoma-speciﬁc monoclonal antibody AE3 was investigated using carbo-
hydrate microarray technology.
Introduction
Sulphoglycolipids are acidic glycosphingolipids that contain
one or two sulphate (HSO3
−) groups, and are components of
cell membranes.1 To date, several sulphoglycolipids have been
isolated and characterised.1,2 Interestingly, many of them have
the same glycan sequence as ganglio-series3 or globo-series
gangliosides4 but they contain sulphate groups instead of
sialic acid residues. These sulphated glycolipids with a
ganglio-series core framework are found in mammalian
nervous tissue and in the kidney, where they may play a role in
osmotic adaptation.5 In addition, many of these sulphated glyco-
lipids are known to be associated with various carcinomas.6
SB1a, for instance, a di-sulphated analogue of the sialoglyco-
lipid GD1a, has been found to be abundantly expressed on the
surface of the human hepatocellular carcinoma cell line PLC/
PRF/15 but not in glycolipid extracts from a cirrhotic liver or
normal liver.6a Although association has been suggested
between sulphoglycolipid accumulation and cancerous beha-
viours of epithelial cancer cells,6b–d,7 the precise roles of these
sulphoglycolipids in carcinomas and other biological systems
has not been clarified. To elucidate these roles, structurally
homogeneous forms of sulphoglycolipids are in great demand.
In the course of searching for carbohydrate sequences recognized
by the epithelial cancer-specific monoclonal antibody (mAb)
AE3, microarray analyses were performed with approximately
500 sequence-defined glycan probes. These revealed an
unpredicted binding of the antibody to SM1a,8 the mono-
sulphated analogue of the sialoglycolipid GM1. The mAb AE3
was bound relatively weakly to the three structurally-related
gangliosides asialo-GM1, GM1 and GM1 (Gc). There was no
binding to the di-sulphated analogue SB1a. As the SM1a and
SB1a included in the screening analyses were from natural
sources, it was important to rule out the presence of any
minor contaminants which could not be detected by mass
spectrometry. The structures of SM1a (1) and SB1a (2), which
were first isolated from rat kidney,9 were assigned as shown in
Fig. 1.9,2a Characteristically, their ceramide compositions were
mainly C24 non-hydroxylated fatty acids (tetracosanoic acid)
and C18 4-hydroxysphinganine (D-ribo-phytosphingosine). Very
recently, Li and co-workers reported the first total synthesis of
SM1a; however, its ceramide part consisted of unnatural un-
saturated sphingosine.10 Previously, our group accomplished
the syntheses of a large number of sialoglycans, including ganglio-
sides11 and their sulphated analogues,12 using a chemical
approach. Here we report the first total syntheses of the di-
sulphated glycolipid SB1a and the monosulphated SM1a, each
with a ceramide tail as found in natural products. The binding
of the synthesized sulphoglycolipids by mAb AE3 was investi-
gated using carbohydrate microarray technology.
Fig. 1 Structures of SM1a and SB1a.
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Results and discussion
Fig. 2 presents the retrosynthetic analyses of the target com-
pounds. Obviously, the systematic synthesis of SB1a and
SM1a is possible because they have a gangliotetraose skeleton
and a ceramide part. The key disconnection toward total syn-
thesis is performed between the inner galactose and the redu-
cing end glucose residues to produce key fragments, i.e. the
non-reducing end trisaccharide unit and the glucosyl cera-
mide (GlcCer) cassette. Each C3 position of the galactose
residues should be protected by the diﬀerent selectively remov-
able protecting groups because they are potential sites to intro-
duce the sulphate group. To date, we have succeeded in the
eﬃcient total synthesis of natural gangliosides such as GQ1b,13
GalNAc-GD1a,14 GalNAc-GM1b,15 X2,16 LLG-3 17 and GAA-7,18
using the GlcCer cassette approach.19 This approach has been
proven to be able to overcome a long-standing issue in glyco-
lipid synthesis, namely that coupling of the flexible, poor reac-
tive ceramide acceptor and the oligosaccharyl donor results in
low yield and loss of the valuable oligosaccharide unit. Encour-
aged by previous successes, we decided to apply the GlcCer
cassette approach to the present total syntheses. The present
GlcCer cassette 4 was designed as shown in Fig. 2 and could
be divided into the known glucose 7 and ceramide 8 deriva-
tives. The common trisaccharyl donor 3 could be assembled
from the known monosaccharide derivatives 5 and 6.
First, following the above synthetic strategy, the common
trisaccharyl donor 3 was prepared from the known galactose
derivative 5 20 and N-Troc-protected galactosamine derivative
6.21 As shown in Scheme 1, selective introduction of the benzyl
group at the C3 position of 5 was performed in a one-pot
fashion with two steps, tin acetal formation and subsequent
benzylation, giving the 4-OH galactosyl acceptor 9 in 93%
yield. The benzyl group was extremely stable under both acidic
and basic reaction conditions, and it could be chemoselec-
tively removed by hydrogenolysis prior to sulphonation.
Thereafter, the non-reducing end galactose unit was also
prepared from 5. The 3-OH of 5 was selectively protected as a
levulinoyl ester by treatment with levulinic acid, EDC·HCl and
DMAP in CH2Cl2 at −20 °C, aﬀording 10 in 88% yield. Regio-
selectivity was produced on the basis of the diﬀerence in reactiv-
ity between equatorial 3-OH and axial 4-OH. The selectively
removable Lev group in the presence of other acyl protecting
groups was installed for SB1a. After acetylation of 4-OH (giving
11), the p-methoxyphenyl (pMP) group at the anomeric position
was removed with CAN and H2O in an optimised mixed solvent
system22 to give hemiacetal 12 in 81% yield. Finally, the intro-
duction of the trichloroacetimidoyl group23 yielded the non-
reducing end galactosyl donor 13 in a nearly quantitative yield.
Scheme 2 illustrates the synthesis of the inner disaccharide
GalNβ(1 → 4)Gal acceptor 16. The glycosylation of 9 with the
known galactosaminyl donor 6 equipped with the 2,2,2-tri-
chloroethoxycarbonyl (Troc) group at C2 as a β-stereo-directing
element was performed in the presence of NIS and TfOH24 in
Fig. 2 Retrosynthetic analysis of the target compounds, SB1a and
SM1a.
Scheme 1 Synthesis of galactose derivatives 9 and 13.
Scheme 2 Synthesis of disaccharide acceptor 16.
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CH2Cl2 at −40 °C, giving disaccharide 14 as a single β-isomer
in 76% yield. The reductive removal of the Troc group by treat-
ment with zinc and acetic acid in MeCN gave the amino deriva-
tive 15 in good yield. MeCN was selected as a solvent to obtain
the pure amino derivative before the following acetyl migration
step because our previous study on the synthesis of a ganglio-
side found that MeCN eﬀectively suppressed random acetyl
group migration.17 To rapidly convert 15 into the acceptor
form 16, acetyl migration from 3-O to 2-N was exerted.
Although this reaction was attempted several times under
diﬀerent conditions, the undesired formation of 17, which was
the over-migrated product from 4-O to 3-O, could not be
avoided. The results are summarised in Table 1. As shown in
entry 1, the reaction was performed in 1,4-dioxane under
acidic conditions at 60 °C. The migration of the acetyl group
was very sluggish and prolonged reaction time increased the
generation of the over-migrated side-product 17. Moreover,
19% of 15 were recovered. In entry 2, to facilitate acetyl
migration, the reaction temperature was increased up to 90 °C.
However, the reaction was an abysmal failure, providing a
complex mixture after 16 h. Changing the solvent to DMF did
not aﬀect the outcome significantly (entry 3). However, in
AcOH/DMF 1 : 4 at 90 °C (entry 4), the reaction time decreased
and the best result (56% of 16) was obtained. Although basic
conditions using triethylamine were also examined, the yield
of 16 was not improved (entry 5).
As shown in Scheme 3, access to the trisaccharyl donor 3 as
a pivotal common unit began with glycosylation of 16 with 13
in the presence of TMSOTf in CH2Cl2 at 0 °C, giving trisacchar-
ide 18 in 77% yield. The selective removal of the p-methoxy-
phenyl group with CAN and H2O followed by the introduction
of the trichloroacetimidoyl group aﬀorded the common tri-
saccharyl donor 3 in 80% yield over two steps.
Scheme 4 shows the assembly of the targeted tetrasaccharyl
ceramide framework. First, the GlcCer cassette 4 was con-
structed by the coupling of the known glucosyl donor 7 16 and
ceramide acceptor 8 25 mediated by a NIS-TfOH promoter
system in CH2Cl2 at 0 °C to aﬀord 20 in 71% yield. A previous
study on the GlcCer cassette approach has shown the impor-
tance of the protection of hydroxyl groups in the Glc residue to
increase the reactivity of the 4-OH of the GlcCer cassette. The
best combination for protection was the presence of electron-
donating groups on both O4 and O6 and an electron-withdraw-
ing group on O2.13–15 Furthermore, the TBDMS protection of
the C4 hydroxy group on a Glc donor is also important for
eﬃcient coupling of glucose and ceramide.17 Thus, we used
the Glc donor 7 in this study. The removal of the TBDMS
group in 20 by exposure to TBAF gave an 87% yield of the
GlcCer cassette 4, which was the coupling partner for the tri-
saccharyl donor 3 in the final glycosylation.
The key glycosylation reaction performed between the equi-
molar amounts of trisaccharyl donor 3 and GlcCer cassette 4
was allowed to proceed in the presence of a catalytic amount of
TMSOTf in CH2Cl2 at 0 °C, providing the tetrasaccharyl ceramide
framework 21 in 72% yield. Following this, the p-methoxy-
benzyl groups in 21 were removed under acidic conditions
(giving 22). Subsequent acetylation aﬀorded 23, which was
used for the following reaction sequences as the core frame-
work of both target compounds.
Table 1 Examination of 3-O to 2-N acetyl migration toward 16
Entry Additive/solvent
Temp.
(°C)
Time
(h) Yield of 16 (%)
Yield of
17 (%)
Recovered
15 (%)
1 AcOH/1,4-dioxane (1 : 4) 60 78 51 19 30
2 AcOH/1,4-dioxane (1 : 4) 90 16 Complex mixture —
3 AcOH/DMF (1 : 4) 60 48 49 19 32
4 AcOH/DMF (1 : 4) 90 4 56 18 26
5 Et3N/DMF (1 : 4) 60 72 49 11 40
Scheme 3 Synthesis of common trisaccharide donor 3.
Scheme 4 Synthesis of GlcCer cassette 4 followed by glycosylation
with 3.
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The selective removal of the benzyl group in 23 by hydro-
genation was examined. The results are summarised in
Table 2. The Pearlman’s catalyst (Pd(OH)2–C) was chosen as a
Pd catalyst and the reaction was performed in EtOAc under
ambient pressure of H2 gas. Consequently, only a poor yield
(5%) of the desired product 24 was obtained and most of the
starting material 23 was recovered (entry 1). Although increas-
ing the Pd catalyst amount gave a marginally better result
(9%), the eﬀect was very limited (entry 2). As entry 3 shows,
the reaction solvent was changed to EtOH, which has been
often used as a solvent for hydrogenolysis. After stirring for
72 h under ambient pressure, the reaction was subsequently
subjected to a work-up process, providing 24 in 50% yield.
Further prolonged stirring produced unwanted by-products,
one of which was identified as a product in which the benzene
ring of the benzoyl groups was reduced. The separation of the
crude mixture of 24 and by-products by silica gel column
chromatography was a laborious task. We speculated that
steric hindrance surrounding the benzyl group made access of
the benzyl group onto the surface of palladium carbon
diﬃcult.
Toward solving the problem, the reaction was carried out
under a H2 atmosphere at higher pressure (0.3 MPa) (entry 4).
As anticipated, the reaction rate became faster and the yield of
24 was increased up to 77%. Although reduction of the
benzene ring of the benzoyl group was observed, the limited
reaction time (<24 h) minimised the formation of the by-
product. The hydroxyl group of the obtained 24 was available
for sulphonation toward SM1a.
Scheme 5 shows the final steps to mono-sulphated glyco-
sphingolipid SM1a. For sulphonation of the hydroxyl group at
the C3 position of the inner galactose residue, 24 was reacted
with SO3·Pyr in pyridine at 80 °C, yielding 25 in 91% yield.
Finally, saponification of whole acyl protecting groups using
0.5 M aq. NaOH in MeOH was performed to furnish one of the
target compounds SM1a (1) as an Na form in good yield.
SB1a was also derived from 24 via three steps (Scheme 6).
First, the levulinoyl group was removed by treatment with
NH2NH2·AcOH in THF, giving diol 26 in excellent yield.
Sulphonation of two hydroxyl groups was performed using the
same procedure as that of SM1a, aﬀording the fully protected
SB1a 27 in 96% yield. Finally, cleavage of acyl groups under
saponification conditions successfully delivered the targeted
SB1a (2) in excellent yield.
The synthetic sulphoglycolipids SM1a and SB1a were
printed in a small focused microarray together with the natu-
rally occurring SM1a. The array was then probed with mAb
AE3 to compare the binding signals elicited (Fig. 3). The syn-
thetic and the naturally occurring SM1a were equally well
Table 2 Removal of the benzyl group in 23, giving 24
Entry
Equiv. of Pd
(OH)2-C Solvent
Pressure
(MPa)
Time
(h)
% Yield of
24
1 0.1 EtOAc — 24 5
2 1.8 EtOAc — 11 9
3 3.6 EtOH — 72 50
4 3.6 EtOH 0.3 23 77
Scheme 5 Sulphonation followed by global deprotection toward SM1a.
Scheme 6 Conversion of 24 into SB1a through sulphonation followed
by deprotection.
Fig. 3 Microarray analyses of mAb AE3 with the naturally occurring and
chemically synthesized SM1a and synthetic SB1a. The results shown are
binding intensities with duplicated spots of the three glycolipids printed
at 5 fmol in the arrays with error bars representing half of the diﬀerence
between the two values.
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bound by mAb AE3, whereas there were no binding signals
with the synthetic disulphated glycolipid SB1a. This result
corroborated the previous finding in the screening array analysis
that AE3 binding was restricted to the monosulphated glyco-
lipid SM1a with an unsubstituted terminal galactose residue.
Sulphation of this galactose, as in SB1a, obviated the AE3
binding.
Conclusions
The total synthesis of disulphated glycosphingolipid SB1a was
accomplished for the first time, as well as synthesis of the
related monosulphated SM1a with a natural ceramide moiety.
These glycolipids were systematically synthesised by eﬃcient
glycan assembly using common building blocks and the
GlcCer cassette approach. The success of the total synthesis of
sulphoglycolipids demonstrates the broad utility of the GlcCer
cassette approach for glycolipid synthesis. Furthermore,
binding analysis using the two synthetic sulphoglycolipids
corroborated the previous observations on the recognition of
the SM1a glycolipid by mAb AE3, although the antibody was
originally raised against a cancer-associated mucin-type glyco-
protein. These findings raise the possibility that sulphated
O-glycan analogs of SM1a occur on cancer-associated mucins.
Experimental section
General methods
All reactions were carried out under a positive pressure of
argon, unless otherwise noted. All chemicals were purchased
from commercial suppliers and used without further purifi-
cation, unless otherwise noted. Molecular sieves were pur-
chased from Wako Chemicals Inc. (Miyazaki, Japan) and dried
at 300 °C for 2 h in a muﬄe furnace prior to use. Solvents as
reaction media were dried over molecular sieves and used
without purification. TLC analysis was performed on Merck
TLC plates (silica gel 60F254 on glass plates). Compound detec-
tion was either by exposure to UV light (2536 Å) or by soaking
in a solution of 10% H2SO4 in ethanol followed by heating.
Silica gel (80 mesh and 300 mesh) manufactured by Fuji
Silysia Co. was used for flash column chromatography. The
quantity of silica gel was usually estimated as 100 to 200-fold
weight of the sample to be charged. Solvent systems in chromato-
graphy were specified in v/v. Evaporation and concentration
were carried out in vacuo. 1H-NMR and 13C-NMR spectra were
recorded with Bruker AVANCE III 500/800 spectrometers.
Chemical shifts in 1H-NMR spectra are expressed in ppm (δ)
relative to the signal of Me4Si, adjusted to δ 0.00 ppm. Data are
presented as follows: Chemical shift, multiplicity (s = singlet,
d = doublet, t = triplet, dd = double of doublet, td = triple
doublet, m = multiplet and/or multiple resonances), inte-
gration, coupling constant in hertz (Hz), position of the corres-
ponding proton. COSY methods were used to confirm the
NMR signal assignments. The sugar units were numbered with
Roman numerals I, II, III, IV beginning at the reducing
(“upstream”) end of the molecule. The individual resonances
were numbered with Roman numeral superscripts as, for
example, the following: H-3I, H-3II, H-3III, H-3IV. High-resolu-
tion mass (ESI-TOF MS) spectra were run on the Bruker
micrOTOF. Optical rotations were measured with a “Horiba
SEPA-300” high-sensitive polarimeter.
Synthetic procedures
4-Methoxyphenyl 2,6-di-O-benzoyl-3-O-benzyl-β-D-galacto-
pyranoside (9). A mixture of 5 (205 mg, 0.41 mmol) and di-
n-butyltin(IV) oxide (116 mg, 0.45 mmol) in toluene (8.2 mL) was
refluxed for 31 h with the azeotropic removal of water using
Dean–Stark apparatus. The mixture was then cooled to 80 °C,
and benzyl bromide (54 µL, 0.45 mmol) and tetrabutyl-
ammonium bromide (145 mg, 0.45 mmol) were added to the
mixture. After stirring for 13 h at 80 °C as the reaction was
monitored by TLC (CHCl3/MeOH 15 : 1), the reaction mixture
was quenched with a solution of cesium fluoride (5 wt% in
H2O). The mixture was extracted with CHCl3, and then the
organic layer was washed with brine, dried over Na2SO4, and
concentrated. The resulting residue was purified by silica
gel column chromatography (CHCl3/MeOH 80 : 1) to give 9
(223 mg, 93%) as an amorphous compound; [α]D +38.0° (c 1.0,
CHCl3);
1H NMR (500 MHz, CDCl3) δ 8.07–7.15 (m, 15H, Ph),
6.89–6.57 (2 d, 4H, Ar), 5.72 (dd, 1H, J1,2 8.1 Hz, J2,3 9.7 Hz,
H-2), 4.91 (d, 1H, H-1), 4.76–4.64 (m, 3H, H-6a, H-6b, PhCH2),
4.57 (d, 1H, Jgem 12.3 Hz, PhCH2), 4.16 (s, 1H, H-4), 3.95 (m,
1H, H-5), 3.75 (dd, 1H, J3,4 3.4 Hz, H-3), 3.67 (s, 3H, OCH3),
2.76 (s, 1H, OH); 13C NMR (125 MHz, CDCl3) δ 166.3, 165.3,
155.4, 151.3, 136.9, 133.2, 133.1, 129.9, 129.8, 128.5, 128.4,
128.4, 128.1, 127.9, 118.8, 114.3, 100.9, 78.2, 72.6, 71.8, 71.0,
66.2, 63.5, 55.5; HRMS (ESI) m/z: found [M + Na]+ 607.1936,
C34H32O9 calcd for [M + Na]
+ 607.1939.
4-Methoxyphenyl 2,6-di-O-benzoyl-3-O-levulinoyl-β-D-galacto-
pyranoside (10). To a solution of 5 (200 mg, 0.40 mmol) in
CH2Cl2 (8 mL) were added 4-oxopentanoic acid (61 µL,
0.60 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
hydrochloride (115 mg, 0.60 mmol), and 4-dimethyl-
aminopyridine (4.9 mg, 40 µmol) at −20 °C. After stirring for
4 h at −20 °C as the reaction was monitored by TLC (CHCl3/
MeOH 15 : 1), the reaction mixture was diluted with CHCl3,
and then successively washed with water and brine, dried over
Na2SO4, and concentrated. The resulting residue was purified
by crystallization (n-hexane/EtOAc) to give 10 (207 mg, 88%)
as a white crystal; M.p. 94–96 °C (from n-hexane/EtOAc);
[α]D +32.0° (c 1.0, CHCl3);
1H NMR (500 MHz, CDCl3)
δ 8.07–7.42 (m, 10H, Ph), 6.93–6.61 (2 d, 4H, Ar), 5.83 (dd, 1H,
J1,2 8.1 Hz, J2,3 10.3 Hz, H-2), 5.13 (dd, 1H, J3,4 3.2 Hz, H-3),
5.04 (d, 1H, H-1), 4.72–4.65 (m, 2H, H-6a, H-6b), 4.32 (dd, 1H,
J4,OH 7.3 Hz, H-4), 4.09 (dd, 1H, J5,6a 6.1 Hz, J5,6b 6.5 Hz, H-5),
3.69 (s, 3H, OCH3), 3.22 (d, 1H, OH), 2.74–2.44 (m, 4H,
CH2CH2), 2.13 (s, 3H, CH3);
13C NMR (125 MHz, CDCl3)
δ 208.0, 171.9, 166.3, 155.5, 151.2, 133.3, 133.2, 129.8, 129.7,
129.5, 128.4, 128.4, 118.9, 114.3, 101.0, 74.1, 72.6, 69.4, 66.6,
Organic & Biomolecular Chemistry Paper
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63.2, 55.5, 38.2, 29.6, 28.3; HRMS (ESI) m/z: found [M + Na]+
615.1837, C32H32O11 calcd for [M + Na]
+ 615.1837.
4-Methoxyphenyl 4-O-acetyl-2,6-di-O-benzoyl-3-O-levulinoyl-
β-D-galactopyranoside (11). To a solution of 10 (360 mg,
0.61 mmol) in THF (6.1 mL) were added acetic anhydride
(87 µL, 0.92 mmol) and 4-dimethylaminopyridine (7.5 mg,
0.061 mmol) at ambient temperature. After stirring for 30 min
as the reaction was monitored by TLC (CHCl3/MeOH 25 : 1),
the reaction mixture was quenched with MeOH and diluted
with EtOAc. The organic layer was then washed with satd aq.
NaHCO3 and brine, dried over Na2SO4, and concentrated. The
resulting residue was purified by silica gel column chromato-
graphy (CHCl3/MeOH 100 : 1) to give 11 (384 mg, 99%) as an
amorphous compound; [α]D +14.4° (c 3.0, CHCl3);
1H NMR
(500 MHz, CDCl3) δ 8.04–7.42 (m, 10H, Ph), 6.92–6.63 (2 d, 4H,
Ar), 5.77 (dd, 1H, J1,2 8.1 Hz, J2,3 10.4 Hz, H-2), 5.62 (d, 1H,
J3,4 3.3 Hz, H-4), 5.33 (dd, 1H, H-3), 5.10 (d, 1H, H-1), 4.56 (dd,
1H, J5,6a 7.6 Hz, Jgem 11.3 Hz, H-6a), 4.44 (dd, 1H, J5,6b 5.6 Hz,
H-6b), 5.62 (t, 1H, H-5), 3.68 (s, 3H, OCH3), 2.65–2.39 (m, 4H,
CH2CH2), 2.23 (s, 3H, CH3), 2.01 (s, 3H, Ac);
13C NMR
(125 MHz, CDCl3) δ 205.6, 171.6, 170.1, 165.8, 165.1, 155.5,
150.9, 133.3, 133.2, 129.7, 129.6, 129.33, 129.2, 128.3, 118.7,
114.3, 100.9, 71.1, 71.1, 69.2, 67.2, 61.2, 55.4, 37.5, 29.3, 27.7,
20.1; HRMS (ESI) m/z: found [M + Na]+ 657.1946, C34H34O12
calcd for [M + Na]+ 657.1942.
4-O-Acetyl-2,6-di-O-benzoyl-3-O-levulinoyl-D-galactopyranose
(12). To a solution of 11 (670 mg, 1.06 mmol) in acetonitrile/
toluene/H2O (6/5/3, 10.6 mL) was added ammonium cerium(IV)
nitrate (5.81 g, 10.6 mmol) at 0 °C. After stirring for 15 min at
0 °C as the reaction was monitored by TLC (CHCl3/MeOH
50 : 1), the reaction mixture was diluted with EtOAc. The
organic layer was successively washed with satd aq. NaHCO3
and brine, dried over Na2SO4, and concentrated. The resulting
residue was purified by silica gel column chromatography
(CHCl3/MeOH 150 : 1 → 100 : 1) to give 12 (455 mg, α/β 5 : 1,
81%) as a white solid; 1H NMR (500 MHz, CDCl3) δ 8.05–7.42
(m, 12.2H, Ph), 5.70–5.68 (m, 2H, H-1α, H-2α), 5.62 (dd, 1H,
J3,4 3.3 Hz, J4,5 1.0 Hz, H-4α), 5.56 (d, 0.2H, J3,4 1.8 Hz, H-4β),
5.39 (dd, 1H, J2,3 10.0 Hz, H-3α), 5.35–5.33 (m, 0.4H, H-2β,
H-3β), 4.87 (t, 0.2H, J1,2 8.0 Hz, J1,OH 8.2 Hz, H-1β), 4.65 (t, 1H,
J5,6a, J5,6b 6.7 Hz, H-5α), 4.53 (dd, 0.2H, J5,6a 6.6 Hz, Jgem 11.3
Hz, H-6aβ), 4.47 (dd, 1H, Jgem 11.3 Hz, H-6aα), 4.36 (dd, 0.2H,
J5,6b 6.9 Hz, H-6bβ), 4.29 (dd, 1H, J5,6b 6.9 Hz, H-6bα), 4.15
(t, 0.2H, H-5β), 4.10 (d, 0.2H, OHβ), 3.43 (d, 1H, OHα),
2.73–2.37 (m, 5H, CH2CH2α,β), 2.19 (s, 3.6H, CH3α,β), 2.04
(s, 3.7H, Acα,β); 13C NMR (125 MHz, CDCl3) δ 206.0, 171.8,
170.3, 166.1, 166.0, 133.7, 133.5, 133.3, 130.0, 129.7, 129.4,
129.2, 128.5, 128.4, 96.2, 90.9, 71.9, 71.1, 70.5, 69.0, 68.4, 67.5,
67.4, 66.4, 62.1, 61.8, 37.7, 37.7, 29.6, 29.5, 27.8, 27.7, 20.7,
20.6; HRMS (ESI) m/z: found [M + Na]+ 551.1524, C27H28O11
calcd for [M + Na]+ 551.1524.
4-O-Acetyl-2,6-di-O-benzoyl-3-O-levulinoyl-α-D-galactopyrano-
syl trichloroacetimidate (13). To a solution of 12 (450 mg,
0.86 mmol) in CH2Cl2 (8.5 mL) were added trichloroaceto-
nitrile (2.4 mL, 17 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene
(100 µL, 0.94 mmol) at 0 °C. After stirring for 1 h at 0 °C as the
reaction was monitored by TLC (CHCl3/MeOH 20 : 1), the reac-
tion mixture was concentrated and then purified by silica gel
column chromatography (CHCl3/MeOH 100 : 1) to give 13
(572 mg, 99%) as an amorphous compound; [α]D +77.7° (c 0.6,
CHCl3);
1H NMR (500 MHz, CDCl3) δ 8.59 (s, 1H, NH),
8.01–7.41 (m, 10H, Ph), 6.76 (dd, 1H, J1,2 3.0 Hz, H-1),
5.73–5.66 (m, 3H, H-2, H-3, H-4), 4.65 (t, 1H, J5,6a, J5,6b 6.6 Hz,
H-5), 4.48 (dd, 1H, Jgem 11.4 Hz, H-6a), 4.36 (dd, 1H, H-6b),
2.72–2.42 (m, 4H, CH2CH2), 2.22 (s, 3H, CH3), 2.06 (s, 3H, Ac);
13C NMR (125 MHz, CDCl3) δ 205.8, 171.7, 170.1, 165.8, 165.5,
160.5, 133.6, 133.3, 129.9, 129.7, 129.3, 128.7, 128.4, 128.4,
93.6, 90.7, 69.3, 67.8, 67.7, 67.4, 61.9, 37.7, 29.5, 27.7, 20.6;
HRMS (ESI) m/z: found [M + Na]+ 694.0615, C29H28Cl3NO11
calcd for [M + Na]+ 694.0620.
4-Methoxyphenyl [3,4,6-tri-O-acetyl-2-deoxy-2-(2,2,2-tri-
chloroethoxycarbamoyl)-β-D-galactopyranosyl]-(1 → 4)-2,6-di-
O-benzoyl-3-O-benzyl-β-D-galactopyranoside (14). 4 Å Mole-
cular sieves (1.75 g), 6 (501 mg, 0.875 mmol), 9 (511 mg,
0.875 mmol), and NIS (236 mg, 1.05 mmol) were suspended in
CH2Cl2 (17.5 mL) at ambient temperature. After stirring for
30 min, the mixture was cooled to −40 °C. TfOH (9.3 µL,
0.105 mmol) was then added to the mixture, which was stirred
for 30 min at −40 °C as the reaction was monitored by TLC
(CHCl3/EtOAc 5 : 1). The reaction mixture was quenched with
satd aq. NaHCO3 and then filtered through a pad of Celite,
and then washed with CHCl3. The combined filtrate and wash-
ings were washed with satd aq. Na2S2O3 and brine, dried over
Na2SO4, and concentrated. The resulting residue was purified
by silica gel column chromatography (CHCl3/EtOAc 25 : 1 →
15 : 1 → 5 : 1) and the product obtained was then subjected to
crystallization to give 14 (696 mg, 76%) as a white crystal;
M.p. 187 °C (from n-hexane/EtOAc); [α]D +1.5° (c 1.0, CHCl3);
1H NMR (500 MHz, CDCl3) δ 8.07–7.22 (m, 15H, Ph), 6.89–6.56
(2 d, 4H, Ar), 5.71 (dd, 1H, J1,2 8.2 Hz, J2,3 9.9 Hz, H-2
II), 5.38
(br d, 1H, J2,NH 7.4 Hz, NH
III), 5.32 (d, 1H, J3,4 2.9 Hz, H-4
III),
4.98 (br d, 1H, J2,3 10.3 Hz, H-3
III), 4.90 (d, 1H, H-1II), 4.86 (d,
1H, Jgem 12.1 Hz, Cl3CCH2), 4.80 (d, 1H, J1,2 8.5 Hz, H-1
III),
4.76–4.71 (m, 2H, H-6aII, Cl3CCH2), 4.65 (d, 1H, Jgem 11.6 Hz,
PhCH2), 4.60–4.57 (m, 2H, H-6b
II, PhCH2), 4.20 (d, 1H, J3,4 1.7
Hz, H-4II), 4.12–4.05 (m, 2H, H-5III, H-6aIII), 3.98–3.91 (m, 2H,
H-5II, H-2III), 3.83–3.68 (m, 2H, H-6bIII, H-3II), 3.67 (s, 3H,
OCH3), 2.15, 2.03, 1.97 (3 s, 9H, 3Ac);
13C NMR (125 MHz,
CDCl3) δ 170.4, 170.2, 170.2, 166.3, 164.9, 155.4, 154.4, 151.4,
136.8, 133.2, 133.2, 129.9, 129.8, 129.7, 129.7, 128.8, 128.5,
128.5, 128.1, 118.8, 114.3, 101.6, 101.1, 96.0, 79.4, 74.4, 74.1,
73.5, 72.3, 71.4, 70.7, 70.4, 66.6, 64.0, 61.3, 55.5, 52.7, 20.6,
20.6, 20.5; HRMS (ESI) m/z: found [M + Na]+ 1068.1985,
C49H50Cl3NO18 calcd for [M + Na]
+ 1068.1986.
4-Methoxyphenyl (3,4,6-tri-O-acetyl-2-amino-2-deoxy-
β-D-galactopyranosyl)-(1 → 4)-2,6-di-O-benzoyl-3-O-benzyl-
β-D-galactopyranoside (15). To a solution of 14 (442 mg,
0.42 mmol) in acetonitrile/AcOH (4 : 1, 8.4 mL) was added zinc
powder (2.1 g). After stirring for 20 min at ambient tempera-
ture as the reaction was monitored by TLC (CHCl3/MeOH
15 : 1), the reaction mixture was filtered through a pad of
Celite, and then washed with EtOAc. The filtrate and washings
Paper Organic & Biomolecular Chemistry
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were combined and extracted with EtOAc. The organic layer
was successively washed with satd aq. NaHCO3 and brine,
dried over Na2SO4, and concentrated. The resulting residue
was purified by silica gel column chromatography (CHCl3/
MeOH 100 : 1) to give 15 (342 mg, 93%) as a white solid; [α]D
+38.0° (c 0.2, CHCl3);
1H NMR (500 MHz, CDCl3) δ 8.07–7.18
(m, 15H, Ph), 6.89–6.55 (2 d, 4H, Ar), 5.80 (dd, 1H, J1,2 8.1 Hz,
J2,3 10.0 Hz, H-2
II), 5.32 (d, 1H, J3,4 2.6 Hz, H-4
III), 4.92 (d, 1H,
H-1II), 4.74–4.70 (m, 2H, H-3III, H-6aIII), 4.67–4.57 (m, 3H,
H-6bIII, PhCH2), 4.52 (d, 1H, J1,2 7.9 Hz, H-1
III), 4.21 (d, 1H, J3,4
2.7 Hz, H-4II), 4.14–4.07 (m, 2H, H-6aIII, H-6bIII), 3.94 (dd, 1H,
J5,6a 4.1 Hz, J5,6b 8.1 Hz, H-5
II), 3.82 (dd, 1H, J5,6a 6.6 Hz, J5,6b
7.3 Hz, H-5III), 3.76 (dd, 1H, J2,3 10.5 Hz, H-3
II), 3.67 (s, 3H,
OCH3), 3.29 (dd, 1H, J2,3 10.8 Hz, H-2
III), 2.13, 2.05, 2.02 (3 s,
9H, 3Ac), 1.65 (s, 2H, NH2);
13C NMR (125 MHz, CDCl3)
δ 170.4, 170.4, 170.3, 166.3, 165.2, 155.4, 151.4, 137.0, 133.2,
133.2, 129.9, 129.8, 129.7, 128.5, 128.5, 128.4, 128.2, 128.0,
118.6, 114.3, 105.3, 100.9, 78.7, 74.2, 73.9, 72.6, 72.5, 71.2,
70.7, 66.3, 64.1, 61.7, 55.5, 51.8, 20.8, 20.7, 20.6; HRMS (ESI)
m/z: found [M + Na]+ 894.2944, C46H49NO16 calcd for [M + Na]
+
894.2944.
4-Methoxyphenyl (2-acetamido-4,6-di-O-acetyl-2-deoxy-
β-D-galactopyranosyl)-(1 → 4)-2,6-di-O-benzoyl-3-O-benzyl-
β-D-galactopyranoside (16). A solution of 15 (100 mg, 0.115 mmol)
in AcOH/DMF (1 : 4, 11.5 mL) was stirred for 4 h at 90 °C as
the reaction was monitored by TLC (CHCl3/MeOH 20 : 1). The
reaction mixture was neutralized with ice-cooled satd aq.
NaHCO3 and extracted with EtOAc. The organic layer was then
washed with H2O and brine, dried over Na2SO4, and concen-
trated. The resulting residue was purified by silica gel column
chromatography (CHCl3/MeOH 80 : 1) to give 16 (56 mg, 56%)
as an amorphous compound; [α]D +14.0° (c 0.5, CHCl3);
1H
NMR (500 MHz, CDCl3) δ 8.08–7.14 (m, 15H, Ph), 6.89–6.57
(m, 5H, Ar, NH), 6.08 (d, 1H, J1,OH 2.0 Hz, OH), 5.75 (dd, 1H,
J1,2 8.1 Hz, J2,3 9.9 Hz, H-2
II), 5.27 (d, 1H, J3,4 3.2 Hz, H-4
III),
4.92 (d, 1H, J1,2 8.1 Hz, H-1
II), 4.77 (dd, 1H, J5,6a 3.7 Hz, Jgem
12.1 Hz, H-6aII), 4.66 and 4.62 (2 d, 2H, Jgem 10.7 Hz, PhCH2),
4.28 (dd, 1H, J5,6b 8.1 Hz, Jgem 12.1 Hz, H-6b
II), 4.47 (d, 1H, J1,2
8.6 Hz, H-1III), 4.19 (d, 1H, J3,4 2.9 Hz, H-4
II), 4.12 (d, 2H,
H-6aIII, H-6bIII), 4.00 (dd, 1H, J5,6a 3.6 Hz, J5,6b 8.1 Hz, H-5
II),
3.92–3.88 (m, 2H, H-2III, H-3II), 3.77 (t, 1H, J5,6a, J5,6b 6.4 Hz,
H-5III), 3.68 (s, 3H, OCH3), 3.58 (m, 1H, H-3
III), 2.16, 2.05, 1.90
(3 s, 9H, 3Ac); 13C NMR (125 MHz, CDCl3) δ 175.2, 170.6,
170.4, 166.4, 165.1, 155.5, 151.2, 135.8, 133.5, 133.3, 129.8,
129.7, 129.5, 129.1, 128.9, 128.6, 128.6, 128.5, 118.8, 114.3,
102.5, 100.7, 80.0, 75.8, 74.5, 74.0, 72.3, 71.4, 71.3, 68.0,
64.0, 62.1, 55.8, 55.5, 22.6, 20.8, 20.7; HRMS (ESI) m/z: found
[M + Na]+ 894.2944, C46H49NO16 calcd for [M + Na]
+ 894.2944.
4-Methoxyphenyl (4-O-acetyl-2,6-di-O-benzoyl-3-O-levulinoyl-
β-D-galactopyranosyl)-(1 → 3)-(2-acetamido-4,6-di-O-acetyl-
2-deoxy-β-D-galactopyranosyl)-(1 → 4)-2,6-di-O-benzoyl-3-
O-benzyl-β-D-galactopyranoside (18). 4 Å Molecular sieves (1.1 g,
MS AW300), 13 (571 mg, 0.840 mmol) and 16 (472 mg,
0.540 mmol) were suspended in CH2Cl2 (17.5 mL) at ambient
temperature. After stirring for 30 min, the mixture was cooled
to 0 °C. TMSOTf (9.8 µL, 0.054 mmol) was then added to the
mixture, which was stirred for 93 h at 0 °C as the reaction was
monitored by TLC (CHCl3/MeOH 20 : 1). The reaction mixture
was quenched with satd aq. NaHCO3 and filtered through a
pad of Celite, and then washed with CHCl3. The combined fil-
trate and washings were washed with satd aq. Na2S2O3 and
brine, dried over Na2SO4, and concentrated. The resulting
residue was purified by silica gel column chromatography
(CHCl3/EtOAc 25 : 1 → 15 : 1 → 5 : 1) and the product was then
subjected to crystallization to give 18 (574 mg, 77%) as a white
crystal; M.p. 184 °C (from n-hexane/EtOAc); [α]D +160.0° (c 0.2,
CHCl3);
1H NMR (500 MHz, CDCl3) δ 8.06–7.07 (m, 25H, Ph),
6.81–6.50 (2 d, 4H, Ar), 5.62–5.58 (m, 2H, NH, H-2II), 5.52 (d,
1H, J3,4 3.0 Hz, H-4
IV), 5.46–5.42 (m, 2H, H-4III, H-2IV), 5.22
(dd, 1H, J2,3 10.5 Hz, J3,4 3.4 Hz, H-3
IV), 5.18 (d, 1H, J1,2 8.3 Hz,
H-1III), 5.05 (dd, 1H, J2,3 10.9 Hz, J3,4 3.4 Hz, H-3
III), 4.81 (d,
1H, J1,2 8.1 Hz, H-1
IV), 4.78 (d, 1H, J1,2 7.9 Hz, H-1
II), 4.63 (dd,
1H, J5,6b 3.7 Hz, Jgem 12.2 Hz, H-6a
II), 4.58–4.48 (m, 3H, H-6aIV,
H-6bII, PhCH2), 4.36 (d, 1H, Jgem 12.8 Hz, PhCH2), 4.31 (dd,
1H, J5,6b 7.1 Hz, Jgem 11.2 Hz, H-6b
IV), 4.10–4.02 (m, 2H, H-5IV,
H-6aIII), 3.99 (d, 1H, J3,4 2.5 Hz, H-4
II), 3.94 (dd, 1H, J5,6b
6.8 Hz, Jgem 11.5 Hz, H-6b
III), 3.84 (dd, 1H, J5,6b 8.3 Hz, H-5
II),
3.79 (t, 1H, H-5III), 3.64 (s, 3H, OCH3), 3.56 (dd, 1H, J2,3
10.0 Hz, H-3II), 3.24–3.19 (m, 1H, H-2III), 2.63–2.36 (m, 4H,
CH2CH2), 2.21, 2.15, 2.01, 1.72 (4 s, 15H, 3Ac, CH3);
13C NMR
(125 MHz, CDCl3) δ 205.7, 172.6, 171.7, 170.5, 170.3, 170.0,
166.2, 165.8, 165.1, 165.0, 155.3, 151.3, 137.1, 133.6, 133.2,
129.9, 129.8, 129.8, 129.7, 129.7, 129.7, 129.5, 129.4, 128.7,
128.4, 128.4, 128.3, 128.0, 118.6, 114.2, 101.7, 100.8, 99.1, 78.0,
74.4, 72.9, 72.4, 71.9, 71.0, 70.7, 69.4, 67.1, 64.2, 62.5,
61.5, 55.5, 37.7, 29.6, 29.4, 27.8, 23.2, 20.8, 20.7, 20.7; HRMS
(ESI) m/z: found [M + Na]+ 1404.4469, C73H75NO26 calcd for
[M + Na]+ 1404.4470.
(4-O-Acetyl-2,6-di-O-benzoyl-3-O-levulinoyl-β-D-galacto-
pyranosyl)-(1 → 3)-(2-acetamido-4,6-di-O-acetyl-2-deoxy-
β-D-galactopyranosyl)-(1 → 4)-2,6-di-O-benzoyl-3-O-benzyl-
D-galactopyranosyl trichloroacetimidate (3). To a solution of 18
(335 mg, 0.242 mmol) in acetonitrile/toluene/H2O (6 : 5 : 3,
12 mL) was added ammonium cerium(IV) nitrate (1.33 g,
2.40 mmol) at 0 °C. After stirring for 40 min as the reaction
was monitored by TLC (CHCl3/MeOH 20 : 1), the reaction
mixture was extracted with EtOAc. The organic layer was suc-
cessively washed with satd aq. NaHCO3 and brine, dried over
Na2SO4, and concentrated. The resulting residue was purified
by silica gel column chromatography (CHCl3/MeOH 150 : 1 →
100 : 1) to give 19. The obtained residue was then dissolved in
CH2Cl2 (12 mL). To the solution were added trichloroacetoni-
trile (685 µL, 4.84 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-
ene (283 µL, 2.66 mmol) at 0 °C. After stirring for 1 h as the
reaction was monitored by TLC (CHCl3/MeOH 20 : 1), the reac-
tion mixture was concentrated and then purified by silica
gel column chromatography (CHCl3/MeOH 80 : 1) to give 3
(275 mg, 80% over 2 steps) as an amorphous compound; 3α:
[α]D +42.9° (c 1.2, CHCl3);
1H NMR (500 MHz, CDCl3) δ 8.39
(s, 1H, CvNH), 8.05–7.14 (m, 25H, Ph), 6.51 (d, 1H, J1,2 3.6 Hz,
H-1II), 5.64 (dd, 1H, J2,3 10.4 Hz, H-2
II), 5.51–5.49 (m, 2H, NHII,
H-4III), 5.21 (dd, 1H, J2,3 10.5 Hz, J3,4 3.5 Hz, H-3
IV), 5.17
Organic & Biomolecular Chemistry Paper
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(d, 1H, J1,2 8.3 Hz, H-1
III), 4.98 (dd, 1H, J2,3 10.8 Hz, J3,4 3.5 Hz,
H-3III), 4.77 (d, 1H, J1,2 7.9 Hz, H-1
IV), 4.63–4.58 (m, 2H, H-6aIV,
PhCH2), 4.52 (dd, 1H, J5,6b 6.4 Hz, Jgem 11.3 Hz, H-6a
II), 4.43
(d, 1H, Jgem 12.5 Hz, PhCH2), 4.38–4.29 (m, 3H, H-5
IV, H-6bIV,
H-6bII), 4.15 (d, 1H, J3,4 2.0 Hz, H-4
II), 4.09–4.00 (m, 3H, H-3II,
H-5II, H-6aIII), 3.91 (dd, 1H, J5,6b 7.2 Hz, Jgem 11.6 Hz, H-6b
III),
3.78 (t, 1H, H-5III), 3.24–3.19 (m, 1H, H-2III), 2.64–2.34 (m, 4H,
CH2CH2), 2.20–1.36 (5 s, 15H, 4Ac, CH3);
13C NMR (125 MHz,
CDCl3) δ 205.6, 172.1, 171.7, 170.4, 170.2, 169.9, 166.2, 165.8,
165.3, 164.9, 160.2, 137.1, 133.5, 133.3, 133.1, 133.0, 129.8,
129.7, 129.6, 129.5, 129.5, 129.4, 129.2, 128.6, 128.4, 128.3,
128.3, 127.9, 101.7, 99.2, 94.1, 90.9, 74.7, 74.0, 73.9, 71.9, 71.6,
71.0, 70.9, 70.7, 69.4, 69.2, 68.5, 67.0, 64.5, 62.6, 61.4, 60.3,
55.3, 37.6, 29.6, 29.4, 27.7, 23.0, 20.8, 20.7, 20.6; HRMS (ESI)
m/z: found [M + Na]+ 1441.3147, C68H69Cl3N2O25 calcd for
[M + Na]+ 1441.3147.
(2-O-Benzoyl-4-O-tert-butyldimethylsilyl-3,6-di-O-p-methoxy-
benzyl-β-D-glucopyranosyl)-(1 → 1)-(2S,3S,4R)-3,4-di-O-benzoyl-
2-tetracosanamido-1,3,4-octadecanetriol (20). 4 Å Molecular
sieves (0.28 g), 7 (104 mg, 0.142 mmol), 8 (124 mg,
0.142 mmol), and NIS (38 mg, 0.17 mmol) were suspended in
CH2Cl2 (17.5 mL) at ambient temperature. After stirring for
30 min, the mixture was cooled to 0 °C. TfOH (9.8 µL,
0.054 mmol) was then added to the suspension, which was
stirred for 1 h at 0 °C as the reaction was monitored by TLC
(toluene/EtOAc 10 : 1). The reaction mixture was quenched
with satd aq. NaHCO3 and filtered through a pad of Celite, and
then washed with CHCl3. The combined filtrate and washings
were washed with satd aq. Na2S2O3 and brine, dried over
Na2SO4, and concentrated. The resulting residue was purified
by silica gel column chromatography (toluene/EtOAc 30 : 1) to
give 20 (150 mg, 71%) as a white solid; [α]D +35.0° (c 0.7,
CHCl3);
1H NMR (500 MHz, CDCl3) δ 8.01–7.35 (m, 15H, Ph),
7.27–6.60 (4 d, 8H, Ar), 6.16 (d, 1H, JNH,2 = 9.0 Hz, NH), 5.58
(dd, 1H, J2,3 7.8 Hz, J3,4 3.5 Hz, H-3
Cer), 5.38–5.35 (m, 1H,
H-4Cer), 5.11 (near t, 1H, J1,2, J2,3 8.5 Hz, H-2
I), 4.56–4.47 (m,
4H, ArCH2, H-1
I, H-2Cer), 4.30–4.15 (2 d, 4H, Jgem 11.7 Hz,
ArCH2), 4.03 (dd, 1H, J1,2 3.6 Hz, Jgem 10.1 Hz, H-1a
Cer), 3.78
and 3.68 (2 s, 6H, OCH3), 3.64 (dd, 1H, H-1b
Cer), 3.59–3.55 (m,
3H, H-3I, H-4I, H-6aI), 3.41 (t, 1H, J5,6a, J5,6b 6.4 Hz, H-5
I), 3.32
(dd, 1H, Jgem 10.6 Hz, H-6b
I), 1.88–1.70 (m, 4H, H-5aCer,
H-5bCer, NHCOCH2), 1.60–1.09 (m, 66H, 33CH2), 0.89–0.83 (m,
6H, 2CH3), 0.81 (s, 9H,
tBu), −0.03, −0.05 (s, 6H, 2SiCH3);
13C NMR (125 MHz, CDCl3) δ 174.0, 166.0, 165.2, 165.1, 159.1,
158.8, 133.1, 132.9, 132.8, 130.3, 130.2, 130.1, 130.0, 129.8,
129.8, 129.7, 129.6, 129.1, 129.0, 128.3, 128.3, 113.7, 113.4,
100.3, 82.7, 74.4, 74.2, 73.7, 73.2, 70.9, 68.9, 66.4, 55.2, 55.0,
47.9, 36.3, 31.9, 29.7, 29.7, 29.6, 29.6, 29.5, 29.5, 29.4, 29.3,
29.2, 29.1, 25.9, 25.5, 25.4, 22.7, 17.9, 14.1, −3.8, −4.8; HRMS
(ESI) m/z: found [M + Na]+ 1518.9706, C73H75NO26 calcd for
[M + Na]+ 1518.9701.
(2-O-Benzoyl-3,6-di-O-p-methoxybenzyl-β-D-glucopyranosyl)-
(1 → 1)-(2S,3S,4R)-3,4-di-O-benzoyl-2-tetracosanamido-1,3,4-
octadecanetriol (4). To a solution of 20 (90 mg, 0.060 mmol)
in THF (3.0 mL) was added tetrabutylammonium fluoride (90 µL,
0.090 mmol, 1.0 M solution in THF) at 0 °C. After stirring
for 6 h at 0 °C as the reaction was monitored by TLC
(n-hexane/EtOAc 2 : 1), the reaction mixture was concentrated.
The residue was purified by silica gel column chromatography
(n-hexane/EtOAc 2 : 1) to give 4 (73 mg, 87%) as a white solid;
[α]D +19.0° (c 1.0, CHCl3);
1H NMR (500 MHz, CDCl3)
δ 8.00–7.26 (m, 15H, Ph), 7.16–6.65 (4 d, 8H, Ar), 6.09 (d, 1H,
JNH,2 9.1 Hz, NH), 5.54 (dd, 1H, J2,3 7.8 Hz, J3,4 3.7 Hz, H-3
Cer),
5.37–5.34 (m, 1H, H-4Cer), 5.06 (dd, 1H, J1,2 7.9 Hz, J2,3 9.3 Hz,
H-2I), 4.63–4.52 (m, 3H, ArCH2, H-2
Cer), 4.41 (d, 1H, H-1I),
4.34–4.26 (2 d, 4H, Jgem 11.5 Hz, ArCH2), 3.99 (dd, 1H, J1,2
3.4 Hz, Jgem 10.1 Hz, H-1a
Cer), 3.79, 3.70 (2 s, 6H, 2OCH3),
3.68–3.56 (m, 3H, H-3I, H-4I, H-1bCer), 3.47–3.37 (m, 3H, H-5I,
H-6aI, H-6bI), 2.87 (s, 1H, OH), 1.91–1.73 (m, 4H, H-5aCer,
H-5bCer, NHCOCH2), 1.46–1.09 (m, 66H, 33CH2), 0.94–0.86 (m,
6H, 2CH3);
13C NMR (125 MHz, CDCl3) δ 172.9, 166.0, 165.2,
165.0, 159.3, 159.1, 133.2, 133.0, 129.8, 129.8, 129.7, 129.6,
129.6, 129.5, 129.3, 128.4, 128.4, 128.3, 113.8, 113.7, 100.6,
81.1, 73.9, 73.7, 73.5, 73.3, 73.1, 72.8, 70.3, 66.8, 55.2, 55.1,
47.8, 36.3, 31.9, 29.7, 29.7, 29.7, 29.7, 29.6, 29.6, 29.5, 29.5,
29.4, 29.3, 29.2, 25.5, 25.4, 22.7, 14.1; HRMS (ESI) m/z: found
[M + Na]+ 1404.8831, C85H123NO14 calcd for [M + Na]
+
1404.8836.
(4-O-Acetyl-2,6-di-O-benzoyl-3-O-levulinoyl-β-D-galactopyrano-
syl)-(1 → 3)-(2-acetamido-4,6-di-O-acetyl-2-deoxy-β-D-galacto-
pyranosyl)-(1 → 4)-(2,6-di-O-benzoyl-3-O-benzyl-β-D-galacto-
pyranosyl)-(1 → 4)-(2-O-benzoyl-3,6-di-O-p-methoxybenzyl-
β-D-glucopyranosyl)-(1 → 1)-(2S,3S,4R)-3,4-di-O-benzoyl-2-
tetracosanamido-1,3,4-octadecanetriol (21). 4 Å Molecular
sieves (200 mg, MS AW300), 3 (90 mg, 0.064 mmol), and 4
(89 mg, 0.064 mmol) were suspended in CH2Cl2 (17.5 mL) at
ambient temperature. After stirring for 30 min, the mixture
was cooled to 0 °C. TMSOTf (9.8 µL, 0.054 mmol) was then
added to the mixture, which was stirred for 6 h at 0 °C as the
reaction was monitored by TLC (CHCl3/MeOH 20 : 1). The reac-
tion mixture was quenched with satd aq. NaHCO3 and filtered
through a pad of Celite, and then washed with CHCl3. The
combined filtrate and washings were washed with satd aq.
Na2S2O3 and brine, dried over Na2SO4, and concentrated. The
resulting residue was purified by gel filtration (Sephadex
LH-20, CHCl3/MeOH 1 : 1) and silica gel column chromato-
graphy (n-hexane/EtOAc 4 : 3 → 1 : 1) to give 21 (122 mg, 72%)
as a white solid; [α]D +28.0° (c 2.4, CHCl3);
1H NMR (500 MHz,
CDCl3) δ 8.03–6.60 (m, 50H, Ar), 6.02 (d, 1H, JNH,2 = 8.9 Hz,
NHCer), 5.53–5.49 (m, 3H, H-4IV, NHIII, H-3Cer), 5.45 (d, 1H, J3,4
3.4 Hz, H-4III), 5.40 (dd, 1H, J1,2 7.9 Hz, J2,3 10.5 Hz, H-2
IV),
5.34–5.30 (m, 2H, H-2II, H-4Cer), 5.17 (dd, 1H, J3,4 3.4 Hz,
H-3IV), 5.09 (d, 1H, J1,2 8.3 Hz, H-1
III), 5.05–4.97 (m, 2H, H-2I,
H-3III), 4.76 (d, 1H, H-1IV), 4.73 (d, 1H, Jgem 10.5 Hz, ArCH2),
4.59 (dd, 1H, J5,6a 5.1 Hz, Jgem 11.8 Hz, H-6a
II), 4.55–4.46 (m,
5H, H-2Cer, H-1II, H-6aIV, ArCH2), 4.31–4.27 (m, 4H, ArCH2,
H-1I, H-6bIV), 4.11–4.05 (m, 2H, H-5IV, H-6bIII), 4.02–3.88 (m,
5H, H-4II, ArCH2, H-4
I, H-1aCer, H-6aIII), 3.84 (dd, 1H, J1b,2
6.9 Hz, Jgem 11.5 Hz, H-1b
Cer), 3.74 (t, 1H, J5,6a, J5,6b 6.1 Hz, H-5
III),
3.69–3.64 (m, 7H, 2OCH3, H-3
I), 3.55 (dd, 1H, Jgem 10.3 Hz,
H-6bIII), 3.46 (t, 1H, J5,6a, J5,6b 6.0 Hz, H-5
II), 3.42 (dd, 1H, J5,6a
3.8 Hz, Jgem 11.4 Hz, H-6a
I), 3.35–3.30 (m, 2H, H-3II, H-6bI),
Paper Organic & Biomolecular Chemistry
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3.19–3.13 (m, 2H, H-5I, H-2III), 2.62–2.31 (m, 4H,
CH3COCH2CH2COO), 2.18–1.93 (4 s, 12H, 3Ac, CH3COCH2CH2-
COO), 1.83–1.69 (m, 4H, H-5aCer, H-5bCer, NHCOCH2),
1.60–1.00 (m, 66H, 33CH2), 0.99–0.81 (m, 6H, 2CH3);
13C NMR
(125 MHz, CDCl3) δ 205.6, 172.9, 172.3, 171.7, 170.4, 170.2,
170.0, 166.2, 165.9, 165.8, 165.1, 165.0, 164.9, 164.9, 159.1,
158.9, 137.3, 133.4, 133.1, 132.9, 132.8, 130.3, 130.2, 130.0,
129.9, 129.7, 129.7, 129.6, 129.5, 129.5, 129.4, 129.2, 128.6,
128.4, 128.4, 128.3, 128.3, 128.1, 127.9, 113.6, 113.4, 101.7,
100.6, 100.2, 99.3, 80.0, 76.2, 75.0, 74.8, 73.9, 73.6, 73.3, 73.1,
72.9, 72.3, 71.9, 71.4, 71.0, 70.9, 70.6, 69.4, 69.2, 67.5, 67.0,
66.7, 63.7, 62.5, 61.4, 55.4, 55.1, 55.0, 47.7, 37.6, 36.2, 31.9,
29.7, 29.7, 29.6, 29.5, 29.5, 29.4, 29.4, 29.3, 29.2, 27.7, 27.7,
25.4, 25.3, 23.0, 22.6, 21.4, 20.7, 20.7, 20.5, 14.1; HRMS (ESI)
m/z: found [M + Na]+ 2662.2887, C151H190N2O38 calcd for
[M + Na]+ 2662.2889.
(4-O-Acetyl-2,6-di-O-benzoyl-3-O-levulinoyl-β-D-galactopyrano-
syl)-(1 → 3)-(2-acetamido-4,6-di-O-acetyl-2-deoxy-β-D-galacto-
pyranosyl)-(1 → 4)-(2,6-di-O-benzoyl-3-O-benzyl-β-D-galacto-
pyranosyl)-(1 → 4)-(2-O-benzoyl-β-D-glucopyranosyl)-(1 → 1)-
(2S,3S,4R)-3,4-di-O-benzoyl-2-tetracosanamido-1,3,4-octa-
decanetriol (22). To a solution of 21 (120 mg, 45.4 µmol) in
CH2Cl2 (1.8 mL) was added trifluoroacetic acid (0.9 mL) at
0 °C. After stirring for 2 h at 0 °C as the reaction was moni-
tored by TLC (CHCl3/MeOH 25 : 1), the reaction mixture was
diluted with CHCl3. The organic layer was successively washed
with ice-cooled satd aq. NaHCO3 and brine. The organic solu-
tion was dried over Na2SO4, and concentrated. The resulting
residue was purified by silica gel column chromatography
(n-hexane/EtOAc 4 : 3) to give 22 (100 mg, 92%) as a white
solid; [α]D +40.0° (c 0.9, CHCl3);
1H NMR (500 MHz, CDCl3) δ
8.05–7.06 (m, 40H, Ph), 6.31 (d, 1H, JNH,2 9.7 Hz, NH
Cer), 5.60
(dd, 1H, J2,3 9.3 Hz, J3,4 2.8 Hz, H-3
Cer), 5.52–5.50 (m, 2H,
H-4IV, NHIII), 5.45–5.32 (m, 4H, H-4III, H-2IV, H-2II, H-4Cer), 5.19
(dd, 1H, J2,3 10.5 Hz, J3,4 3.5 Hz, H-3
IV), 5.08 (d, 1H, J1,2 8.3 Hz,
H-1III), 5.05 (dd, 1H, J1,2 8.1 Hz, J2,3 9.6 Hz, H-2
I), 4.97 (dd, 1H,
J2,3 10.9 Hz, J3,4 3.4 Hz, H-3
III), 4.76 (d, 1H, J1,2 7.9 Hz, H-1
IV),
4.73 (dd, 1H, J5,6a 2.6 Hz, Jgem 12.6 Hz, H-6a
II), 4.53–4.49 (m,
5H, H-1II, H-2Cer, H-6aIV, ArCH2, OH), 4.35 (d, 1H, J1,2 7.9 Hz,
H-1I), 4.32–4.21 (m, 3H, ArCH2, H-6b
IV, H-6bII), 4.07 (t, 1H,
J5,6a, J5,6b 6.9 Hz, H-5
IV), 4.02 (dd, 1H, J5,6a 5.1 Hz, Jgem 11.6 Hz,
H-6aIII), 3.92–3.88 (m, 2H, H-4II, H-6bIII), 3.83 (t, 1H, J2,3,
J3,4 9.3 Hz, H-3
I), 3.78–3.75 (m, 3H, H-1aCer, H-5II, H-5III),
3.64 (t, 1H, J3,4, J4,5 9.2 Hz, H-4
I), 3.50–3.45 (m, 2H, H-1bCer,
H-3II), 3.17–3.10 (m, 2H, H-2III, H-6aI), 3.02 (br d, 1H, J5,6a
9.5 Hz, H-5I), 2.90 (br d, 1H, Jgem 11.7 Hz, H-6b
I), 2.67
(dd, 1H, JOH,6a 3.9 Hz, JOH,6b 10.4 Hz, OH), 2.62–2.21
(m, 4H, CH3COCH2CH2CO), 2.20–2.00 (4 s, 12H, 3Ac,
CH3COCH2CH2CO), 1.97–1.40 (m, 7H, H-5a
Cer, H-5bCer,
NHCOCH2, Ac), 1.38–1.17 (m, 66 H, 33CH2), 0.91–0.85 (m, 6 H,
2CH3);
13C NMR (125 MHz, CDCl3) δ 205.7, 173.0, 171.7, 170.5,
170.2, 169.8, 166.5, 166.1, 165.8, 165.6, 165.0, 164.9, 136.8,
133.2, 132.8, 130.0, 129.9, 129.8, 129.7, 129.6, 129.5, 129.4,
129.3, 129.3, 128.6, 128.5, 128.4, 128.4, 128.3, 128.2, 128.1,
101.7, 99.5, 99.2, 80.4, 77.6, 73.9, 73.7, 73.1, 72.2, 71.9, 71.0,
70.7, 69.4, 69.3, 64.1, 62.6, 61.5, 55.3, 48.0, 37.7, 36.5, 31.9,
29.7, 29.7, 29.6, 29.6, 29.5, 29.5, 29.4, 29.3, 29.3, 29.2, 28.4,
27.8, 25.5, 23.0, 22.6, 20.8, 20.7, 20.7, 14.1; HRMS (ESI) m/z:
found [M + Na]+ 2422.1740, C135H174N2O36 calcd for [M + Na]
+
2422.1739.
(4-O-Acetyl-2,6-di-O-benzoyl-3-O-levulinoyl-β-D-galactopyrano-
syl)-(1 → 3)-(2-acetamido-4,6-di-O-acetyl-2-deoxy-β-D-galacto-
pyranosyl)-(1 → 4)-(2,6-di-O-benzoyl-3-O-benzyl-β-D-galacto-
pyranosyl)-(1 → 4)-(3,6-di-O-acetyl-2-O-benzoyl-β-D-gluco-
pyranosyl)-(1 → 1)-(2S,3S,4R)-3,4-di-O-benzoyl-2-tetracosana-
mido-1,3,4-octadecanetriol (23). To a solution of 22 (62 mg,
0.026 mmol) in pyridine (1.3 mL) was added acetic anhydride
(645 µL, 6.82 mmol) at 0 °C. The progress of the reaction was
monitored by MALDI-TOF MS. After stirring for 9 d at ambient
temperature, pyridine was co-evaporated with toluene. The
residue was diluted with EtOAc, and washed with 2 M HCl,
H2O, satd aq. NaHCO3, and brine. The organic layer was dried
over Na2SO4 and concentrated. The resulting residue was puri-
fied by silica gel column chromatography (CHCl3/MeOH
120 : 1) to give 23 (63 mg, 98%) as a white solid; [α]D +19.0°
(c 1.2, CHCl3);
1H NMR (500 MHz, CDCl3) δ 8.05–7.06 (m, 40H,
Ph), 6.04–6.02 (m, 2H, NHIII, NHCer), 5.53–5.50 (m, 2H, H-3Cer,
H-4IV), 5.45–5.42 (m, 2H, H-4III, H-2IV), 5.32–5.23 (m, 3H,
H-4Cer, H-3I, H-2II), 5.20 (dd, 1H, J2,3 10.5 Hz, J3,4 3.4 Hz,
H-3IV), 5.14 (d, 1H, J1,2 8.3 Hz, H-1
III), 5.05 (dd, 1H, J2,3
10.9 Hz, J3,4 3.4 Hz, H-3
III), 4.98 (dd, 1H, J1,2 7.8 Hz, J2,3 9.7 Hz,
H-2I), 4.79 (d, 1H, J1,2 7.8 Hz, H-1
IV), 4.58 (dd, 1H, J5,6a 4.5 Hz,
Jgem 12.0 Hz, H-6a
II), 4.53–4.48 (m, 3H, H-1II, H-2Cer, H-6aIV),
4.34–4.24 (m, 5H, H-1I, ArCH2, H-6b
IV, H-6bII), 4.07 (t, 1H, J5,6a,
J5,6b 6.8 Hz, H-5
IV), 3.98–3.85 (m, 5H, H-6aIII, H-6aI, H-4II,
H-1aCer, H-6bIII), 3.80–3.73 (m, 2H, H-6bI, H-5III), 3.66 (dd, 1H,
J5,6a 4.7 Hz, J5,6b 8.0 Hz, H-5
II), 3.60 (t, 1H, J3,4, J4,5 9.5 Hz,
H-4I), 3.49–3.43 (m, 2H, H-1bCer, H-3II), 3.37–3.34 (m, 1H,
H-5I), 3.13–3.09 (m, 1H, H-2III), 2.62–2.33 (m, 4H,
CH3COCH2CH2COO), 2.19–1.89 (5 s, 15H, 4Ac, CH3COCH2CH2-
COO), 1.88–1.75 (m, 4H, H-5aCer, H-5bCer, NHCOCH2), 1.62 (s,
3H, Ac), 1.46–1.13 (m, 69H, 33CH2, Ac), 0.91–0.86 (m, 6H,
2CH3);
13C NMR (125 MHz, CDCl3) δ 205.6, 172.8, 172.6, 171.6,
170.4, 170.2, 170.2, 169.8, 166.2, 166.0, 165.8, 165.1, 165.0,
164.8, 164.6, 137.0, 133.4, 133.3, 133.1, 133.0, 132.8, 130.0,
129.8, 129.7, 129.7, 129.6, 129.5, 129.4, 129.3, 129.1, 128.6,
128.6, 128.4, 128.3, 128.2, 128.1, 127.9, 101.6, 100.3, 100.0,
98.8, 78.1, 75.0, 74.4, 73.6, 72.7, 72.6, 72.1, 71.9, 71.8, 71.7,
71.1, 71.0, 70.9, 70.6, 69.3, 67.1, 66.8, 63.7, 62.5, 61.5, 55.4,
47.7, 37.6, 36.3, 31.9, 29.7, 29.6, 29.6, 29.5, 29.5, 29.4, 29.4,
29.3, 29.2, 28.8, 27.7, 25.4, 25.4, 23.0, 22.6, 20.7, 20.7, 20.7,
20.6, 20.3, 14.1; HRMS (ESI) m/z: found [M + Na]+ 2506.1951,
C139H178N2O38 calcd for [M + Na]
+ 2506.1950.
(4-O-Acetyl-2,6-di-O-benzoyl-3-O-levulinoyl-β-D-galactopyrano-
syl)-(1 → 3)-(2-acetamido-4,6-di-O-acetyl-2-deoxy-β-D-galacto-
pyranosyl)-(1 → 4)-(2,6-di-O-benzoyl-β-D-galactopyranosyl)-(1→ 4)-
(3,6-di-O-acetyl-2-O-benzoyl-β-D-glucopyranosyl)-(1→ 1)-(2S,3S,4R)-
3,4-di-O-benzoyl-2-tetracosanamido-1,3,4-octadecanetriol
(24). To a solution of 23 (41 mg, 16.5 µmol) in EtOH
(1.6 mL) was added Pd(OH)2–C (41 mg, 20% on carbon). The
flask containing the mixture was evacuated and filled with H2
gas, which was repeated three times. The mixture was then
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2015 Org. Biomol. Chem., 2015, 13, 11105–11117 | 11113
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
4 
Se
pt
em
be
r 2
01
5.
 D
ow
nl
oa
de
d 
on
 2
9/
01
/2
01
8 
16
:2
2:
49
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
stirred under 0.3 MPa pressure of H2 gas. After stirring for
23 h at ambient temperature as the reaction was monitored by
TLC (CHCl3/MeOH 25 : 1), the reaction mixture was filtered
through a pad of Celite and the precipitate was washed with
EtOH. The filtrate was concentrated and the residue obtained
was purified by silica gel column chromatography (CHCl3/
MeOH 80 : 1) to give 24 (31 mg, 77%) as a white solid;
[α]D +20.5° (c 2.0, CHCl3);
1H NMR (500 MHz, CDCl3) δ 8.05–7.33
(m, 35 H, Ar), 6.08 (d, 1 H, JNH,2 9.3 Hz, NH
Cer), 6.01 (d, 1H,
JNH,2 6.5 Hz, NH
III), 5.54–5.49 (m, 3H, H-3Cer, H-1III, H-4IV),
5.44–5.41 (m, 2H, H-4III, H-2IV), 5.32–5.20 (m, 3H, H-4IV, H-3I,
H-3IV), 5.01–4.94 (m, 2H, H-2II, H-2I), 4.75 (d, 1H, J1,2 7.8 Hz,
H-1IV), 4.59 (dd, 1H, J5,6a 4.6 Hz, Jgem 11.9 Hz, H-6a
II),
4.52–4.45 (m, 3H, H-2Cer, H-3III, H-6aIV), 4.39 (d, 1H, J1,2
7.7 Hz, H-1II), 4.33–4.26 (m, 3H, H-1I, H-6bIV, H-6bII), 4.11–4.07
(m, 2H, H-5IV, H-4II), 4.01–3.94 (m, 2H, H-6aIII, H-6bIII),
3.90–3.83 (m, 3H, H-6aI, H-5III, H-1aCer), 3.77 (dd, 1H, J5,6a 4.8
Hz, J5,6b 7.2 Hz, H-5
II), 3.73–3.64 (m, 3H, H-4I, H-1bCer, H-3II),
3.38 (dd, 1H, J5,6a 3.3 Hz, J5,6b 9.9 Hz, H-5
I), 3.25 (d, 1H, JOH,3
10.1 Hz, OH), 3.14 (m, 1H, H-2III), 2.62–2.32 (m, 4H,
CH3COCH2CH2COO), 2.19, 2.15, 1.99, 1.94, 1.89 (5 s, 15H, 4Ac,
CH3COCH2CH2COO), 1.84–1.76 (m, 4H, H-5a
Cer, H-5bCer,
NHCOCH2), 1.71, 1.59 (2 s, 6H, 2Ac), 1.52–1.13 (m, 66H,
33CH2), 0.94–0.85 (m, 6H, 2CH3);
13C NMR (125 MHz, CDCl3)
δ 205.6, 173.2, 172.8, 171.7, 170.4, 170.3, 170.2, 169.7, 166.2,
166.1, 165.8, 165.1, 165.0, 164.8, 133.7, 133.5, 133.2, 133.1,
132.9, 130.0, 129.9, 129.8, 129.7, 129.7, 129.6, 129.5, 129.5,
129.2, 129.1, 129.1, 128.7, 128.7, 128.6, 128.5, 128.4, 128.3,
101.8, 100.1, 98.9, 75.5, 75.0, 74.6, 73.7, 73.1, 72.7, 72.5, 72.3,
72.0, 71.8, 71.7, 70.9, 69.6, 69.5, 67.0, 67.0, 63.6, 62.4, 62.1,
61.5, 55.9, 47.7, 37.6, 36.3, 31.9, 30.0, 29.7, 29.7, 29.6, 29.6,
29.6, 29.5, 29.5, 29.4, 29.3, 29.2, 28.7, 27.7, 25.5, 25.4, 22.8,
22.7, 20.8, 20.8, 20.7, 20.6, 20.4, 14.1; HRMS (ESI) m/z: found
[M + Na]+ 2416.1478, C132H172N2O38 calcd for [M + Na]
+
2416.1480.
(4-O-acetyl-2,6-di-O-benzoyl-3-O-levulinoyl-β-D-galactopyrano-
syl)-(1 → 3)-(2-acetamido-4,6-di-O-acetyl-2-deoxy-β-D-galacto-
pyranosyl)-(1 → 4)-(2,6-di-O-benzoyl-3-O-sulfo-β-D-galacto-
pyranosyl)-(1 → 4)-(3,6-di-O-acetyl-2-O-benzoyl-β-D-gluco-
pyranosyl)-(1 → 1)-(2S,3S,4R)-3,4-O-benzoyl-2-tetracosana-
mido-1,3,4-octadecanetriol triethylamine salt (25). To a
solution of 24 (10 mg, 4.2 µmol) in pyridine (0.2 mL) was
added the SO3·pyridine complex (13 mg, 0.084 mmol) at 80 °C.
After stirring for 4 h at 80 °C as the reaction was monitored by
TLC (CHCl3/MeOH 15 : 1), the reaction was quenched with tri-
ethylamine, and pyridine was co-evaporated with toluene. The
residue was purified by silica gel column chromatography
(CHCl3/MeOH/Et3N 120 : 1 : 1.2) to give 25 (9.8 mg, 91%) as a
white solid; [α]D +9.8° (c 2.0, CHCl3);
1H NMR (500 MHz,
CDCl3) δ 10.3 (br s, 1H, Et3NH), 8.04–7.33 (m, 35H, Ar), 7.12
(d, 1H, JNH,2 7.3 Hz, NH
III), 6.01 (d, 1H, JNH,2 9.2 Hz, NH
Cer),
5.50–5.48 (m, 2H, H-3Cer, H-4IV), 5.40–5.35 (m, 2H, H-4III,
H-2IV), 5.30–5.27 (m, 1H, H-4Cer), 5.22 (t, 1H, J2,3, J3,4 9.5 Hz,
H-3I), 5.15 (dd, 1H, J2,3 10.5 Hz, J3,4 3.4 Hz, H-3
IV), 5.00 (dd,
1H, J1,2 8.4 Hz, J2,3 9.8 Hz, H-2
II), 4.96–4.92 (m, 2H, H-1III,
H-2I), 4.79 (d, 1H, J1,2 7.8 Hz, H-1
IV), 4.60–4.58 (m, 3H, H-6aII,
H-3II, H-4II), 4.50–4.46 (m, 2H, H-2Cer, H-6aIV), 4.42 (d, 1H, J1,2
8.1 Hz, H-1II), 4.33–4.26 (m, 3H, H-1I, H-6bIV, H-6bII), 4.08 (t,
1H, J5,6a, J5,6b 6.8 Hz, H-5
IV), 4.04–4.00 (m, 2H, H-6aI, H-3III),
3.87–3.74 (m, 6H, H-6aIII, H-6bIII, H-2III, H-5II, H-1aCer, H-6aI),
3.68–3.62 (m, 2H, H-5III, H-4I), 3.47 (dd, 1H, J1b,2 3.7 Hz, Jgem
10.1 Hz, H-1bCer), 3.34–3.31 (m, 1H, H-5I), 3.07–3.03 (m, 6H,
3NCH2CH3), 2.61–2.30 (m, 4H, CH3COCH2CH2CO), 2.18–1.68
(6 s, 18H, 5Ac, CH3COCH2CH2CO), 1.76–1.71 (m, 4H, H-5a
Cer,
H-5bCer, NHCOCH2), 1.49–1.17 (m, 69H, 33CH2, Ac), 0.89–0.83
(m, 6H, 2CH3);
13C NMR (125 MHz, CDCl3) δ 205.7, 172.8,
171.6, 170.6, 170.1, 170.0, 169.4, 166.0, 165.9, 165.0, 165.0,
164.9, 133.4, 133.3, 133.1, 132.9, 130.0, 129.7, 129.6, 129.6,
129.4, 129.1, 128.6, 128.6, 128.5, 128.5, 128.4, 128.3, 101.7,
99.8, 77.6, 76.0, 73.5, 72.8, 72.3, 71.3, 71.1, 70.9, 69.8, 69.4,
67.2, 62.6, 61.7, 47.7, 46.0, 37.6, 36.3, 31.9, 30.0, 29.7, 29.7,
29.6, 29.6, 29.5, 29.5, 29.5, 29.4, 29.3, 29.2, 28.8, 27.7, 25.4,
25.4, 22.8, 22.7, 20.7, 20.6, 20.6, 20.4; HRMS (ESI) m/z: found
[M − H]− 2472.1078, C138H186N2O41S calcd for [M − H]−
2472.1083.
SM1a (1). To a solution of 25 (9.8 mg, 3.8 µmol) in MeOH
(0.28 mL) was added NaOH aq. (0.5 M solution, 480 µL) at
ambient temperature. After stirring for 48 h at ambient temp-
erature as the reaction was monitored by TLC (CHCl3/MeOH/
20 mM ZnCl2 aq. 12 : 9 : 2), the reaction mixture was concen-
trated. The residue was purified by gel filtration (Sephadex
LH-20, CHCl3/MeOH/H2O 5 : 4 : 1) to give 1 (4.5 mg, 82%); [α]D
+15.0° (c 0.5, CHCl3/MeOH/H2O 5 : 4 : 1);
1H NMR (500 MHz,
CD3OD) δ 4.56 (d, 1H, J1,2 8.6 Hz, H-1
III), 4.33 (d, 1H, J1,2
7.8 Hz, H-1), 4.27 (d, 1H, J1,2 7.6 Hz, H-1), 4.21 (d, 1H, J1,2 7.8 Hz,
H-1), 4.13 (dd, 1H, J2,3 10.6 Hz, H-2
III), 3.94 (d, 1H, J3,4 2.4 Hz,
H-4III), 2.11 (t, 2H, NHCOCH2CH2), 1.95 (s, 3H, Ac), 1.53–1.15
(m, 68H, 34CH2), 0.80 (2 t, 6H, 2CH3);
13C NMR (200 MHz,
DMSO-d6) δ 171.9, 171.0, 104.6, 103.4, 103.3, 81.0, 80.7, 78.0,
75.9, 75.3, 75.2, 74.8, 73.8, 73.4, 73.2, 73.0, 72.3, 70.7, 70.6,
69.8, 69.6, 69.1, 68.2, 67.2, 65.2, 62.8, 60.8, 60.5, 60.2, 59.4,
39.9, 31.4, 31.3, 30.7, 29.3, 29.28, 29.21, 29.20, 29.16, 29.1,
29.0, 28.8, 28.73, 28.70, 25.5, 25.4, 23.3, 22.2, 22.1, 14.0; HRMS
(ESI) m/z: found [M − H]− 1435.8351, C138H186N2O41S calcd for
[M − H]− 1435.8352.
(4-O-Acetyl-2,6-di-O-benzoyl-β-D-galactopyranosyl)-(1 → 3)-
(2-acetamido-4,6-di-O-acetyl-2-deoxy-β-D-galactopyranosyl)-(1 → 4)-
(2,6-di-O-benzoyl-β-D-galactopyranosyl)-(1 → 4)-(3,6-di-O-acetyl-
2-O-benzoyl-β-D-glucopyranosyl)-(1 → 1)-(2S,3S,4R)-3,4-di-
O-benzoyl-2-tetracosanamido-1,3,4-octadecanetriol (26). To a
solution of 24 (47 mg, 19.6 µmol) in DMF (0.39 mL) was
added hydrazine acetate (8.8 mg, 98.0 µmol) at ambient temp-
erature. After stirring for 2 h at ambient temperature as the
reaction was monitored by TLC (CHCl3/MeOH 15 : 1), the reac-
tion mixture was diluted with EtOAc and successively washed
with satd aq. NH4Cl and brine. The organic layer was then
dried over Na2SO4 and concentrated. The resulting residue was
purified by silica gel column chromatography (CHCl3/MeOH
60 : 1) to give 26 (42 mg, 93%) as a colorless syrup; [α]D +19.8°
(c 0.6, CHCl3);
1H NMR (500 MHz, CDCl3) δ 8.07–7.33 (m, 35H,
Ph), 6.34 (d, 1H, J2,NH 6.3 Hz, NH
III), 6.22 (d, 1H, J2,NH 9.2 Hz,
NHCer), 5.55 (dd, 1H, J2,3 8.6 Hz, J3,4 3.3 Hz, H-3
Cer), 5.48
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(d, 1H, J1,2 7.9 Hz, H-1
III), 5.43 (2 d, 2H, J3,4 3.5 Hz, H-4
IV,
H-4III), 5.29 (m, 1H, H-4Cer), 5.24, 5.23 (2 t, 2H, H-3I, H-2IV),
4.99 and 4.98 (2 t, J1,2 7.8 Hz, 2H, H-2
III, H-2II), 4.71 (d, 1H, J1,2
7.8 Hz, H-1IV), 4.60 (dd, 1H, Jgem 11.8 Hz, J5,6a 4.6 Hz, H-6a
II),
4.52–4.45 (m, 3H, H-2II, H-3III, H-6aIV), 4.37 (d, 1H, H-1II), 4.32
(d, 1H, J1,2 7.7 Hz, H-1
I), 4.31–4.28 (m, 3H, H-6bIV, H-6bII), 4.09
(d, 1H, J3,4 2.4 Hz, H-4
II), 4.01–3.93 (m, 4H, H-3IV, H-5IV,
H-6aIII, H-5III), 3.86–3.77 (m, 4H, OH, H-1aCer, H-6bIII, H-5II),
3.71–3.67 (m, 2H, H-3II, H-4I), 3.63 (t, 1H, Jgem 9.5 Hz, J5,6a 9.5
Hz, H-6aI), 3.47 (dd, 1H, Jgem 9.7 Hz, J1b,2 3.5 Hz, H-1b
Cer),
3.37–3.32 (m, 2H, H-6bI, H-5I), 3.14 (m, 1H, H-2III), 2.66 (d, 1H,
J3,OH 5.5 Hz, OH), 2.19–1.74 (m, 16H, 4Ac, 2CH2), 1.68 and
1.64 (2 s, 6H, 2Ac), 1.47–1.12 (m, 66H, 33CH2), 0.88, 0.87 (2 t,
6H, 2CH3);
13C NMR (125 MHz, CDCl3) δ 173.3, 172.9, 171.1,
170.5, 170.4, 170.3, 169.7, 166.3, 166.2, 166.1, 165.9, 165.8,
165.2, 164.8, 133.7, 133.2, 133.1, 132.9, 130.1, 129.9, 129.85,
129.80, 129.76, 129.71, 129.70, 129.6, 129.5, 129.4, 129.3,
129.1, 128.7, 128.6, 128.5, 128.44, 128.40, 128.3, 101.5, 100.2,
99.1, 77.6, 75.3, 74.9, 74.7, 73.8, 73.3, 73.1, 73.0, 72.7, 72.4,
72.3, 72.0, 71.8, 71.7, 71.3, 71.0, 69.7, 69.6, 67.0, 63.7, 62.5,
62.1, 62.0, 55.9, 47.8, 36.3, 31.9, 29.74, 29.65, 29.60, 29.56,
29.55, 29.49, 29.35, 29.2, 28.6, 25.5, 25.4, 23.0, 22.7, 20.8, 20.7,
20.6, 20.4, 14.1; HRMS (ESI) m/z: found [M + Na]+ 2318.1113,
C127H166N2O36 calcd for [M + Na]
+ 2318.1113.
(4-O-Acetyl-2,6-di-O-benzoyl-3-O-sulfo-β-D-galactopyranosyl)-
(1 → 3)-(2-acetamido-4,6-di-O-acetyl-2-deoxy-β-D-galactopyrano-
syl)-(1 → 4)-(2,6-di-O-benzoyl-3-O-sulfo-β-D-galactopyranosyl)-
(1 → 4)-(3,6-di-O-acetyl-2-O-benzoyl-β-D-glucopyranosyl)-(1 → 1)-
(2S,3S,4R)-3,4-di-O-benzoyl-2-tetracosanamido-1,3,4-octadeca-
netriol triethylamine salt (27). To a solution of 26 (33 mg, 14.4
µmol) in pyridine (1.4 mL) was added the SO3·pyridine
complex (46 mg, 0.288 mmol) at 80 °C. After stirring for 2 h at
80 °C as the reaction was monitored by TLC (CHCl3/MeOH
15 : 1), the reaction was quenched with triethylamine. Pyridine
was then co-evaporated with toluene. The resulting residue
was purified by silica gel column chromatography (CHCl3/
MeOH/Et3N 30 : 1 : 0.2) and then gel filtration (Sephadex
LH-20, CHCl3/MeOH 1 : 1) was performed to give 27 (37 mg,
96%) as a white solid; [α]D +9.8° (c 2.0, CHCl3);
1H NMR
(500 MHz, CDCl3) δ 9.50 (br s, 2H, Et3NH), 7.99–7.27 (m, 35H,
Ph), 6.97 (d, 1H, J2, NH 9.0 Hz, NH
III), 5.98 (d, 1H, J2, NH 9.2 Hz,
NHCer), 5.70 (d, 1H, J3,4 3.3 Hz, H-4
III), 5.42 (dd, 1H, H-3Cer),
5.31 (d, 1H, J3,4 3.1 Hz, H-4
III), 5.25 (dd, 1H, J1,2 7.8 Hz, J2,3
10.1 Hz, H-2IV), 5.22 (m, 1H, H-4Cer), 5.15 (t, 1H, J2,3, J3,4 9.5
Hz, H-3I), 4.92 (dd, 1H, J1,2 7.8 Hz, J3,4 9.7 Hz, H-2
I), 4.76 (d,
1H, J1,2 7.4 Hz, H-1
III), 4.70 (d, 1H, H-1IV), 4.61 (dd, 1H, H-3IV),
4.53 (dd, 1H, Jgem 12.3 Hz, J5,6a 3.3 Hz, H-6a
III), 4.49–4.45 (m,
2H, H-3II, H-4II), 4.41 (m, 1H, H-2Cer), 4.33 (d, 1H, H-1II),
4.31–4.19 (m, 4H, H-1I, H-3II, H-6bIII, H-6aII), 3.96 (t, 1H, J5,6
6.5 Hz, H-5III), 3.93 (near d, 1H, Jgem 10.7 Hz, H-6a
IV),
3.86–3.70 (m, 5H, H-2III, H-1aCer, H-6aI, H-6bIV, H-5II),
3.57–3.52 (m, 3H, H-4I, H-6bI, H-5IV), 3.40 (dd, 1H, Jgem 13.0
Hz, J1b,2 4.7 Hz, H-1b
Cer), 3.27 (m, 1H, H-5I), 3.01 (2 q, 12H,
2NCH2CH3), 2.19–1.60 (m, 19H, 5Ac, 2CH2), 1.39–1.04 (m,
89H, Ac, 34CH2, 6NCH2CH3), 0.80 (2 t, 6H, 2CH3);
13C NMR
(125 MHz, CDCl3) δ 173.0, 172.9, 170.6, 170.2, 170.0, 169.9,
169.6, 167.7, 166.2, 166.1, 166.0, 165.3, 165.2, 165.1, 164.9,
133.5, 133.4, 133.1, 133.0, 132.9, 132.4, 130.9, 130.1, 130.0,
129.9, 129.8, 129.7, 129.66, 129.64, 129.55, 129.53, 129.4,
129.0, 128.7, 128.6, 128.5, 128.48, 128.40, 128.36, 128.30,
128.25, 103.0, 102.0, 101.2, 99.8, 78.1, 77.7, 77.3, 76.4, 76.2,
74.9, 73.7, 72.8, 72.7, 72.3, 71.5, 71.2, 71.1, 70.2, 69.8, 69.5,
68.6, 68.1, 66.9, 64.3, 62.8, 62.5, 61.8, 51.5, 47.7, 46.9, 46.8,
46.5, 38.7, 36.2, 31.9, 30.3, 30.0, 29.7, 29.6, 29.5, 29.49, 29.47,
29.4, 29.3, 29.2, 29.1, 28.9, 28.4, 25.4, 25.3, 23.7, 22.9, 22.6,
22.3, 20.8, 20.7, 20.6, 202, 14.1, 14.0, 10.9, 9.0, 8.8, 8.6; HRMS
(ESI) m/z: found [M − H + Na]− 2476.0103, C127H164N2O42S2
calcd for [M − H + Na]− 2476.0103.
SB1a (2). To a solution of 27 (77 mg, 16.8 µmol) in MeOH
(0.34 mL) was added NaOH aq. (1.0 M solution, 0.34 mL) at
ambient temperature. After stirring for 48 h at ambient temp-
erature as the reaction was monitored by TLC (CHCl3/MeOH/
5% CaCl2 aq. 84 : 45 : 10), the reaction mixture was concen-
trated. The resulting residue was purified by silica gel column
chromatography (Iatrobeads, CHCl3/MeOH/H2O 6 : 4 : 0 →
6 : 4 : 0.5) to give 2 (28 mg, 96%); [α]D +13.0° (c 0.5, CHCl3/
MeOH/H2O 5 : 4 : 1);
1H NMR (500 MHz, CD3OD) δ 4.47 (d, 1H,
J1,2 7.1 Hz, H-1), 4.43 (d, 1H, J1,2 7.6 Hz, H-1), 4.30 (2 d, 2H, J1,2
7.9 Hz, 2 H-1), 2.21 (t, 2H, Jgem, J1,2 7.2 Hz, H-1a
Cer, H-1bCer),
2.07 (br s, 3H, Ac), 1.63–1.16 (m, 68H, 34CH2), 0.89 (2 t, 6H,
2CH3);
13C NMR (200 MHz, DMSO-d6) δ 171.9, 170.4, 104.3,
103.6, 103.5, 103.4, 80.8, 80.2, 79.1, 77.9, 75.7, 75.1, 74.9, 74.8,
74.7, 74.3, 73.9, 73.5, 73.3, 70.6, 69.8, 69.5, 69.04, 69.02, 67.3,
66.2, 60.8, 60.24, 60.18, 59.4, 50.5, 50.2, 50.1, 39.9, 35.6, 35.5,
31.34, 31.32, 30.7, 29.32, 29.27, 29.20, 29.19, 19.15, 29.09,
29.04, 29.03, 29.01, 29.00, 28.8, 28.7, 28.6, 25.5, 25.4, 23.34,
23.30, 22.13, 22.12, 14.0; HRMS (ESI) m/z: found [M − H +
Na]− 1537.7741, C68H126N2O30S2 calcd for [M − H + Na]−
1537.7740.
Microarray construction and analysis
The naturally occurring SM1a and the synthetic SM1a and
SB1a were robotically arrayed in duplicate at 2 and 5 fmol per
spot on nitrocellulose-coated glass slides using a non-contact
instrument as described.26 Antibody binding analyses were
performed essentially as described.27 In brief, after blocking
with 3% w/v bovine serum albumin (Sigma) in HEPES-buﬀered
saline (5 mM HEPES pH 7.4, 150 mM NaCl, 5 mM CaCl2), the
microarray was probed with the undiluted mAb AE3-contain-
ing culture supernatant. Binding was detected using biotiny-
lated anti-mouse IgM (Sigma, μ-chain specific) at a 1 : 200
dilution, followed by Alexa Fluor-647-labelled streptavidin
(1 μg ml−1; Molecular Probes). Imaging and data analysis were
as described.7,28 The results shown are at 5 fmol per spot.
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